Delivery Order SPE2DB20D2014-SPE2DB25FB16U

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $4,829.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, with a completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S. The firm-fixed-price Delivery Order, valued at $1,138.43, has a completion date of May 9, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a $1,037.55 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The order has a firm fixed price and an ultimate completion date of August 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This contract award, valued at $1,886.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of icosapent ethyl 1 gram capsules, a cardiovascular medication, in quantities of 120 capsules per bottle. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. The award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,370.64 delivery order is for the supply of icosapent ethyl 1 gram capsules, a cardiovascular medication. This award is under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical (DLA TPMED) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,579.30 contract is for the delivery of 120-count 1-gram capsules of the prescription drug icosapent ethyl. The contract has a completion date of May 5, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,598.68 firm fixed-price contract is for the delivery of Icosapent Ethyl 1 gram capsules, a cardiovascular medication. The order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) is a $2,668.69 firm-fixed price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 120-count capsules of Icosapent Ethyl, a cardiovascular medication. The award is not designated under any set-aside program. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,657.92 Firm Fixed Price Delivery Order is for the supply of Icosapent Ethyl 1 gram capsules, a prescription medication, with a period of performance through August 16, 2024. The award is not associated with a set-aside program. As a significant federal contractor, Amerisourcebergen provides a wide range of pharmaceutical products and medical...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB16U
    Delivery Order

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,832.04, is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The award does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 6/1/25, 2:57 AM